GovChime

BENCHMARK FETAL BOVINE SERUM - 68 UNITS OF LOT # A423008

Overview

Response deadline
4:00 PM UTC−04:00
Posted
August 24, 2023
Notice type
Presolicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIAID
Place of performance
Bethesda, MD, 20814
Last updated
Dec 4, 2025

Identifiers

Solicitation number
NOI-NIAID-23-2187095
Notice ID
df7e263ad41d492d841a4172ea48cf80

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Gemini Bio Products Inc., to procure: 1) Benchmark Fetal Bovine Serum (FBS), 68 units of Lot number A423008, CAT # 100-106-500 (500ML/ BOTTLE) 2) To include: Shipping to NIH. Clinical Center, 10 Center Drive, Bethesda, MD 20814 FOB Destination, include all shipping, handling and dry ice charges. The Integrative Immunobiology Section of Laboratory of Immune System Biology is interested in how gene expression is orchestrated as cell differentiate from stem cells into effector cells in the immune system. In particular, the laboratory will study how these systems are controlled by gene expression in determining early B cell development. The FBS provided by GeminiBio has proved to be the best option for optimal results in all of our experiments and cell culture for this project. Therefore, FBS from GeminiBio is the only source we can use for our very critical experiments. Gemini Bioproducts has the specific Lot # A423008 and no other Lot # is acceptable. This serum will be used over the term of the project for continuity and the integrity of our data results. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-23-2187095 to Diana Rohlman at by 4:00 pm eastern standard time August 31, 2023. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:NOI-NIAID-23-2187095
  1. Pre-Solicitation

Formal solicitation typically follows within 30–60 days. (estimate)

  1. Pre-SolicitationCurrentAug 24, 2023

    BENCHMARK FETAL BOVINE SERUM - 68 UNITS OF LOT # A423008

    Notice df7e263ad41d492d841a4172ea48cf80 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

NOI-NIAID-23-2187095

Archive Date

Sep 15, 2023

Office Address

BETHESDA, MD, 20892